While modulators and enhancers that target cystic fibrosis transmembrane conductance regulators (CFTR) function are being developed, insulin is currently the only recommended drug for the treatment of CFRD (82). The gene discussed is CFTR; the disease is cystic fibrosis-related diabetes.